NFE2L2 and cancer: Of note, brusatol, an inhibitor of the Nrf2 pathway also appears in the list (with 12 occurrences), apparently reflecting the more recent interest in research into Nrf2 inhibitors as means to treat cancer or to increase its sensitivity to chemotherapy [44].